【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Nanomedicine Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rising level of government participation in R&D funding
3.1.1.2 Introduction of technological advancements in diagnostic procedures
3.1.1.3 Rising usage of nanomedicine in drug delivery technology
3.1.2 Market restraint analysis
3.1.2.1 Side effects associated with intake of nanoparticles and lower adoption rate by patients
3.1.2.2 Hesitant uptake by medical and pharmaceutical industry
3.2 Penetration & Growth Prospect Mapping For Products, 2016 & 2025
3.3 Nanomedicine – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Nanomedicine Market: Product Estimates & Trend Analysis
4.1 Nanomedicine market: product movement analysis
4.2 Therapeutics
4.2.1 Global therapeutics market, 2013 – 2025 (USD Billion)
4.3 Regenerative medicine
4.3.1 Global regenerative medicine market, 2013 – 2025 (USD Billion)
4.4 In-vitro diagnostics
4.4.1 Global in-vitro diagnostics market, 2013 – 2025 (USD Billion)
4.5 In-vivo diagnostics
4.5.1 Global in-vivo diagnostics market, 2013 – 2025 (USD Billion)
4.6 Vaccines
4.6.1 Global vaccines market, 2013 – 2025 (USD Billion)
Chapter 5 Nanomedicine Market: Application Estimates & Trend Analysis
5.1 Nanomedicine market: Application movement analysis
5.2 Clinical oncology
5.2.1 Global clinical oncology market, 2013 – 2025 (USD Billion)
5.3 Infectious diseases
5.3.1 Global infectious diseases market, 2013 – 2025 (USD Billion)
5.4 Clinical cardiology
5.4.1 Global clinical cardiology market, 2013 – 2025 (USD Billion)
5.5 Orthopedics
5.5.1 Global orthopedics market, 2013 – 2025 (USD Billion)
5.6 Others
5.6.1 Global other applications market, 2013 – 2025 (USD Billion)
Chapter 6 Nanomedicine Market: Nanomolecule Type Estimates & Trend Analysis
6.1 Nanomedicine Market: Nanomolecule Type Movement Analysis
6.2 Nanomolecules
6.2.1 Global nanomolecules market, 2013 – 2025 (USD Billion)
6.2.2 Nanoparticles & quantum dots
6.2.2.1 Global nanoparticles & quantum dots market, 2013 – 2025 (USD Billion)
6.2.2.2 Metal & metal compounds
6.2.2.2.1 Global metal & metal compounds nanoparticles market, by type nanoparticles market estimate & forecast, 2014 – 2025 (USD Billion)
6.2.2.2.2 Gold nanoparticles market estimate & forecast, 2014 – 2025 (USD Billion)
6.2.2.2.3 Silver nanoparticles market estimate & forecast, 2014 – 2025 (USD Billion)
6.2.2.2.4 Alumina nanoparticles market estimate & forecast, 2014 – 2025 (USD Billion)
6.2.2.2.5 Iron oxide nanoparticles market estimate & forecast, 2014 – 2025 (USD Billion)
6.2.2.2.6 Gadolinium nanoparticles market estimate & forecast, 2014 – 2025 (USD Billion)
6.2.2.2.7 Other metal & metal oxide nanoparticles market estimate & forecast, 2014 – 2025 (USD Billion)
6.2.2.3 Global metal & metal compound nanoparticles market, by application
6.2.2.3.1 In-vivo Imaging
6.2.2.3.2 Targeted drug delivery
6.2.2.3.3 Proton therapy
6.2.2.3.4 In-vitro assays
6.2.2.3.5 Cell & phantom imaging
6.2.2.4 Liposomes
6.2.2.4.1 Global liposomes market, 2013 – 2025 (USD Billion)
6.2.2.5 Polymer & polymer drug conjugates
6.2.2.5.1 Global polymer & polymer drug conjugates market, 2013 – 2025 (USD Billion)
6.2.2.6 Hydrogel nanoparticles
6.2.2.6.1 Global hydrogel nanoparticles market, 2013 – 2025 (USD Billion)
6.2.2.7 Dendrimers
6.2.2.7.1 Global dendrimers market, 2013 – 2025 (USD Billion)
6.2.2.8 Inorganic nanoparticles
6.2.2.8.1 Global inorganic nanoparticles market, 2013 – 2025 (USD Billion)
6.2.3 Nanoshells
6.2.3.1 Global nanoshells market, 2013 – 2025 (USD Billion)
6.2.4 Nanotubes
6.2.4.1 Global nanotubes market, 2013 – 2025 (USD Billion)
6.2.5 Nanodevices
6.2.5.1 Global nanodevices market, 2013 – 2025 (USD Billion)
Chapter 7 Nanomedicine Market: Regional Estimates & Trend Analysis, by Product, Application, & Nanomolecule Type
7.1 Nanomedicine market share by region, 2016 & 2025
7.2 North America
7.2.1 North America nanomedicine market, 2013 – 2025 (USD Billion)
7.2.2 U.S.
7.2.2.1 U.S. nanomedicine market, 2013 – 2025 (USD Billion)
7.2.3 Canada
7.2.3.1 Canada nanomedicine market, 2013 – 2025 (USD Billion)
7.3 Europe
7.3.1 Europe nanomedicine market, 2013 – 2025 (USD Billion)
7.3.2 Germany
7.3.2.1 Germany nanomedicine market, 2013 – 2025 (USD Billion)
7.3.3 UK
7.3.3.1 UK nanomedicine market, 2013 – 2025 (USD Billion)
7.4 Asia Pacific.
7.4.1 Asia Pacific nanomedicine market, 2013 – 2025 (USD Billion)
7.4.2 Japan
7.4.2.1 Japan nanomedicine market, 2013 – 2025 (USD Billion)
7.4.3 China
7.4.3.1 China nanomedicine market, 2013 – 2025 (USD Billion)
7.5 Latin America
7.5.1 Latin America nanomedicine market, 2013 – 2025 (USD Billion)
7.5.2 Brazil
7.5.2.1 Brazil nanomedicine market, 2013 – 2025 (USD Billion)
7.6 Middle East & Africa
7.6.1 Middle East & Africa nanomedicine market, 2013 – 2025 (USD Billion)
7.6.2 South Africa
7.6.2.1 South Africa nanomedicine market, 2013 – 2025 (USD Billion)
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.3 Company Profiles
8.3.1 Arrowhead Pharmaceuticals, Inc.
8.3.1.1 Company overview
8.3.1.2 CALANDO PHARMACEUTICALS, Inc.
8.3.1.3 Financial performance
8.3.1.4 Product benchmarking
8.3.2 Brigham and Women’s Hospital (BWH)
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.3 Nanospectra Biosciences, Inc.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.4 ABLYNX
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 AMAG Pharmaceuticals
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Bio-Gate AG
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Celgene Corporation
8.3.7.1 Company overview
8.3.7.2 Abraxis BioScience, Inc.
8.3.7.3 Financial Performance
8.3.7.4 Product benchmarking
8.3.7.5 Strategic initiatives
8.3.8 Johnson & Johnson Services, Inc.
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Pfizer, Inc.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Abbott
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Leadiant Biosciences, Inc.
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Teva Pharmaceutical Industries Ltd.
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.13 CYTIMMUNE SCIENCES, INC.
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.13.4 Strategic initiatives
8.3.14 Merck & Co Ltd
8.3.14.1 Company Overview
8.3.14.2 Financial performance
8.3.14.3 Product benchmarking
8.3.14.4 Strategic initiatives
8.3.15 Gilead
8.3.15.1 Company Overview
8.3.15.2 Financial performance
8.3.15.3 Product benchmarking
8.3.16 Epeius Biotechnologies Corporation
8.3.16.1 Company overview
8.3.16.2 Financial performance
8.3.16.3 Product benchmarking
【レポート販売概要】
■ タイトル：ナノ医薬品の世界市場分析：製品別（治療薬、再生医療、診断）、用途別（臨床腫瘍学、感染症）、ナノ分子別（金、銀、酸化鉄、アルミナ）、セグメント予測、2013-2025■ 英文：Nanomedicine Market Analysis By Products, (Therapeutics, Regenerative Medicine, Diagnostics), By Application, (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2013 - 2025
■ 発行日：2017年4月21日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707570
■ 調査対象地域：グローバル
- 車両用盗難防止装置の世界市場予測（～2021年）：ステアリングロック（ハンドルロック）、アラーム、生体認証キャプチャデバイス、イモビライザーThe vehicle anti-theft system market, in terms of value, is projected to grow at a CAGR of 7.76% from 2016 to 2021. The market is estimated to be USD 6.59 Billion in 2016, and is projected to reach USD 9.57 Billion by 2021. The growth of the vehicle anti-theft system market is fueled by increasingly stringent safety regulations, technological advancements, and the growing adoption of biometric tec …
- アジア太平洋のポータブル発電機市場：ディーゼル発電機、ガソリン発電機、ガス発電機About portable generators Generators are backup devices designed to provide temporary AC power by using the supplied fuel, which can be either diesel, gas, or gasoline. Generators, depending on their portability, are classified into two: portable and stationary. Portable generators are the best solutions to provide AC power for standby non-hardwired applications. Low-end models support only a few …
- ヘッドマウントディスプレイ（HMD/スマートグラス）の世界市場About Head Mounted Displays HMD (head mounted displays) comprise small displays with lenses and semi-transparent mirrors embedded in them, which makes them look like a pair of eyeglasses. They are also sometimes referred to as “smart glasses.” A head-mounted display consists of an image source, collimating optics, and a mechanism to mount the device on the head. The device is wearable, and project …
- 打楽器の世界市場2016-2020About Percussion Instruments Percussion instruments are musical instruments that produce sound due to vibrations. These instruments are categorized into idiophones that produce sounds due to vibrations on the surface of the instrument and membranophones that produce sounds due to vibrations on a stretched membrane, which include drums. These membranes are typically made of animal skin or plastics. …
- 水痘生ワクチンの世界市場：製品別（一価水痘生ワクチン、水痘生ワクチンの組み合わせ）、用途別（帯状疱疹予防接種、MMRV予防接種）、プロバイダー別（公共プロバイダー、民間プロバイダー）The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026. Varicella live vaccines contain an attenuated form of the varicella zoster virus. These vaccines help build immunity against varicella zoster virus as the infection can cause serious diseases such as chicken pox and herpes zos …
- 一次性進行型多発性硬化症(Primary Progressive Multiple Sclerosis (PPMS))：治療薬開発パイプライン動向（2015年上半期版）Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015’, provides an overview of the Primary Progressive Multiple Sclerosis (PPMS)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Primary Progressive Multiple Sclerosis …
- 学生RFID追跡の世界市場About Student RFID TrackingRadio-frequency identification (RFID) technology is used to identify and track a product/object attached to a tag (control device) that transmits information to an antenna (an energy converter), which is a part of the RFID systems itself. A student-tracking RFID is used to track a student. The primary objective of purchasing RFID is student security. The other factor res …
- 中古トラックの世界市場2018-202297 pages, November 2018 About this market The influx of newer models and automotive technology improvements are driving truck owners to sell existing vehicles and buy advanced models. This buying cycle among consumers has led to a steady surge in the supply of used trucks. Reduced prices of used trucks and their increased operational quality are expected to increase demand from numerous customer s …
- 日本の輸液装置市場2016-2020About the Infusion Systems Market in Japan An infusion system is an external pump used to deliver regulated amounts of drugs and nutrients to individuals through intravenous, epidural or enteral, and subcutaneous routes. Drugs delivered using the system include antibiotics, insulin and other hormones, pain relief medications, and chemotherapeutics. The system involves the use of needles for the in …
- リアルタイム位置情報システム（RTLS）の世界市場RTLS refers to local positioning systems that are capable of providing real-time data to decision-makers, useful for the growth of their businesses. It also helps users streamline operations, increase resource (asset or personnel) utilization, and enhance productivity, which results in substantial increase in return on investment (ROI) and reduces the costs significantly. RTLS has already carved a …
- 発泡ポリプロピレン（EPP）フォームの世界市場EPP foam, a type of polyolefin foams, is used in different applications such as automotive, packaging, furniture, helmet, sports material, leisure, and construction. EPP foams are recyclable and lightweight among all the competitive foams in the overall polymer foam industry. These foams are converted into molded parts (inserts) as per the requirement of end-use applications. These foams are avail …
- 合わせガラスの世界市場予測（～2022年）：ポリビニルブチラール、イオノプラストポリマーThe laminated glass market is projected to reach USD 23.04 Billion by 2022, at a CAGR of 6.02% from 2017 to 2022. The growing demand from the building & construction industry is expected to drive the laminated glass market. Based on end-use industry, the building & construction industry is estimated to witness a higher growth than the automotive industry between 2017 and 2022. The growth in buildi …
- アーク溶接装置の世界市場2017-2021About Arc Welding EquipmentArc welding is a process used to join two metals; during the process, the ample amount of heat, which is generated, melts the metals and results in binding them when they cool. Technavio’s analysts forecast the global arc welding equipment market to grow at a CAGR of 4.30% during the period 2017-2021. [Covered in this report] The report covers the present scenario and th …
- ヘルスケアCRMの世界市場分析：用途別（コミュニティー・アウトリーチ、ケース・コーディネーション･マネジメント、リレーションシップ・マネジメント）、技術別（クラウドベース、予測、協力的）、セグメント予測、2014-2025The global healthcare CRM market is expected to reach USD 17.4 billion by 2025, according to a new study by Grand View Research Inc. Rising demand for workflow automation and single platform for tracking medical information provides coordination of patient care, service and timely delivery which is expected to drive the industry growth. The healthcare payers, providers and life science companies a …
- 細胞増殖製品の世界市場：試薬、培地、フローサイトメーター、遠心分離機、バイオリアクターThe global cell expansion market consists of various products used for the mass production of cells. The growth of this market is driven by several factors such as increasing government funding for research, high prevalence of chronic diseases, rising company investments for the development of cell-based products, and growing number of GMP-certified production facilities. High potential growth in …
